Range Financial Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Range Financial Group's NVO Position: Q3 2026 in Review
Range Financial Group increased its Novo Nordisk (NVO) stake by 9.5% in Q3 2026, buying an estimated $240K and bringing the position to 59,702 shares worth $2.26M. The position accounts for 0.63% of the portfolio, ranked #50.
Range Financial Group first reported a position in NVO in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.67M in Q4 2021. 1,235 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Range Financial Group held 59,702 shares of Novo Nordisk worth $2.26M as of Q3 2026.
- Range Financial Group bought 5,197 Novo Nordisk shares in Q3 2026, an estimated $240K.
- Novo Nordisk made up 0.63% of Range Financial Group's portfolio in Q3 2026, its #50 holding.
- Range Financial Group first reported a position in Novo Nordisk in Q1 2021 and has held it in 22 quarters since.
- Range Financial Group's Novo Nordisk position peaked at $2.67M in Q4 2021.
- 1,235 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Range Financial Group's 13F filing for Q3 2026, filed 21 Oct 2026.